1-10 of 10
W Brugger
Close
Sort by
Journal Articles

Bendamustine Plus Rituximab Versus CHOP Plus Rituximab in the First-Line Treatment of Patients with Indolent and Mantle Cell Lymphomas - First Interim Results of a Randomized Phase III Study of the StiL (Study Group Indolent Lymphomas, Germany).

Mathias J. Rummel, U. von Gruenhagen, N. Niederle, F. Rothmann, H. Ballo, E. Weidmann, M. Welslau, G. Heil, H. Duerk, M. Stauch, C. Losem, A. Matzdorff, C. Balser, K. Schalk, D. Kofahl-Krause, U. Kaiser, W. Knauf, A. Banat, D. Hoelzer, W. Brugger, on behalf of the StiL
Journal: Blood
Blood (2007) 110 (11): 385.
https://doi.org/10.1182/blood.V110.11.385.385
Published: 2007
Journal Articles

Ex vivo expansion of CD34+ peripheral blood progenitor cells: implications for the expansion of contaminating epithelial tumor cells

W Vogel, D Behringer, S Scheding, L Kanz, W Brugger
Journal: Blood
Blood (1996) 88 (7): 2707–2713.
https://doi.org/10.1182/blood.V88.7.2707.bloodjournal8872707
Published: 1996
Journal Articles

Developmental regulation of myeloid gene expression and demethylation during ex vivo culture of peripheral blood progenitor cells

M Lubbert, W Brugger, R Mertelsmann, L Kanz
Journal: Blood
Blood (1996) 87 (2): 447–455.
https://doi.org/10.1182/blood.V87.2.447.bloodjournal872447
Published: 1996
Journal Articles

Detection of cytomegalovirus DNA in CD34+ cells from blood and bone marrow

D von Laer, U Meyer-Koenig, A Serr, J Finke, L Kanz, AA Fauser, D Neumann- Haefelin, W Brugger, FT Hufert
Journal: Blood
Blood (1995) 86 (11): 4086–4090.
https://doi.org/10.1182/blood.V86.11.4086.bloodjournal86114086
Published: 1995
Journal Articles

Maintenance of transplantation potential in ex vivo expanded CD34(+)- selected human peripheral blood progenitor cells

R Henschler, W Brugger, T Luft, T Frey, R Mertelsmann, L Kanz
Journal: Blood
Blood (1994) 84 (9): 2898–2903.
https://doi.org/10.1182/blood.V84.9.2898.2898
Published: 1994
Journal Articles

Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin

W Brugger, R Henschler, S Heimfeld, RJ Berenson, R Mertelsmann, L Kanz
Journal: Blood
Blood (1994) 84 (5): 1421–1426.
https://doi.org/10.1182/blood.V84.5.1421.1421
Published: 1994
Journal Articles

Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]

W Brugger, KJ Bross, M Glatt, F Weber, R Mertelsmann, L Kanz
Journal: Blood
Blood (1994) 83 (3): 636–640.
https://doi.org/10.1182/blood.V83.3.636.636
Published: 1994
Journal Articles

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin

W Brugger, W Mocklin, S Heimfeld, RJ Berenson, R Mertelsmann, L Kanz
Journal: Blood
Blood (1993) 81 (10): 2579–2584.
https://doi.org/10.1182/blood.V81.10.2579.2579
Published: 1993
Journal Articles

Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony- stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin [see comments]

W Brugger, K Bross, J Frisch, P Dern, B Weber, R Mertelsmann, L Kanz
Journal: Blood
Blood (1992) 79 (5): 1193–1200.
https://doi.org/10.1182/blood.V79.5.1193.1193
Published: 1992
Journal Articles

Defective monocyte-to-macrophage maturation in patients with aplastic anemia

R Andreesen, W Brugger, C Thomssen, A Rehm, B Speck, GW Lohr
Journal: Blood
Blood (1989) 74 (6): 2150–2156.
https://doi.org/10.1182/blood.V74.6.2150.2150
Published: 1989